Matricelf Ltd (TLV:MTLF)
Israel · Delayed Price · Currency is ILS · Price in ILA 263.30
-13.10 (-4.74%)
Jun 4, 2026, 11:37 AM IDT
Matricelf Market Cap
Matricelf has a market cap or net worth of 80.83 million as of June 3, 2026. Its market cap has increased by 61.95% in one year.
Market Cap
80.83M
Enterprise Value
60.69M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
263.30
Market Cap Chart
Since June 20, 2021, Matricelf's market cap has increased from 62.00M to 80.83M, an increase of 30.38%. That is a compound annual growth rate of 5.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 3, 2026 | 80.83M | -46.80% |
| Dec 31, 2025 | 151.94M | 156.50% |
| Dec 31, 2024 | 59.23M | 18.14% |
| Dec 31, 2023 | 50.14M | -7.15% |
| Dec 29, 2022 | 54.00M | -47.98% |
| Dec 30, 2021 | 103.80M | 67.43% |
| Jun 20, 2021 | 62.00M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bonus BioGroup | 443.89M |
| Geffen Residence & Renewal | 322.52M |
| Clal Biotechnology Industries | 44.70M |
| BioLineRx | 41.94M |
| BioLight Life Sciences | 29.82M |
| Can-Fite BioPharma | 19.78M |
| Purple Biotech | 18.65M |
| Evogene | 17.70M |